Corrigendum to ‘Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment’ Neoplasia, Volume 22, Issue 2 (2020) 111–119

• Steven Kregel,
• Chao Wang,
• Xin Han,
• Lanbo Xiao,
• Ester Fernandez-Salas,
• Pushpinder Bawa,
• Brooke L. McCollum,
• Kari Wilder-Romans,
• Ingrid J. Apel,
• Xuhong Cao,
• Corey Speers,
• Shaomeng Wang,
• Arul M. Chinnaiyan

Affiliations

Steven Kregel

Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, 48109, USA

Chao Wang

Departments of Internal Medicine, Pharmacology, and Medicinal Chemistry, University of Michigan, Ann Arbor, MI, 48109, USA

Xin Han

Departments of Internal Medicine, Pharmacology, and Medicinal Chemistry, University of Michigan, Ann Arbor, MI, 48109, USA

Lanbo Xiao

Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, 48109, USA

Ester Fernandez-Salas

Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, 48109, USA; Departments of Internal Medicine, Pharmacology, and Medicinal Chemistry, University of Michigan, Ann Arbor, MI, 48109, USA

Pushpinder Bawa

Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, 48109, USA

Brooke L. McCollum

Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA

Kari Wilder-Romans

Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, 48109, USA

Ingrid J. Apel

Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, 48109, USA

Xuhong Cao

Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, 48109, USA; Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, MI, 48109, USA

Corey Speers

Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, 48109, USA; Departments of Internal Medicine, Pharmacology, and Medicinal Chemistry, University of Michigan, Ann Arbor, MI, 48109, USA

Shaomeng Wang

Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, 48109, USA; Departments of Internal Medicine, Pharmacology, and Medicinal Chemistry, University of Michigan, Ann Arbor, MI, 48109, USA

Arul M. Chinnaiyan

Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, 48109, USA; Department of Urology, University of Michigan, Ann Arbor, MI, 48109, USA; Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, MI, 48109, USA; Correspondence: Arul M. Chinnaiyan